Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Share-based payments - Second Special Fees Agreement (Details)

v3.23.2
Share-based payments - Second Special Fees Agreement (Details) - Second Special Fees Agreement - EUR (€)
2 Months Ended 4 Months Ended 6 Months Ended
Apr. 20, 2022
Jun. 30, 2022
Apr. 20, 2022
Jun. 30, 2023
Jun. 30, 2022
Feb. 25, 2022
Disclosure of terms and conditions of share-based payment arrangement [line items]            
Share based compensation by share based award equity instruments other than options aggregate fair value       € 29,682,000   € 32,250,000
Recognized as a current liability € 4,440,000   € 4,440,000      
Recognized as a non-current liability 1,353,000   1,353,000      
Decrease in equity € 5,793,000          
Share-based payment expenses   € (3,772,000) 6,380,000 6,523,000 € 2,608,000  
Legal fees   (2,471,000) 4,498,000 4,272,000    
Employee benefits expenses   € (1,301,000) € 1,882,000 € 2,251,000